Reconsidering the Psychotomimetic Properties of LSD: Connectome-Based Classification Reveals Partial Overlap with First Episode Psychosis
The acute effects of lysergic acid diethylamide (LSD) have long been compared to early psychosis. Despite this, no studies have compared the acute effects of LSD and psychosis on resting-state functional connectivity (RSFC) with parallel approaches. We used connectome-based classification, a data-driven method, to distinguish between medication-naïve, non-affective first episode psychosis (FEP) and the acute effects of LSD. Separate classifiers were trained to distinguish the acute effects of LSD from placebo and FEP patients from matched healthy controls. The LSD-placebo classifier was then validated on an external LSD-placebo dataset. The network-interaction classifiers with good discriminability were then applied across datasets to evaluate whether LSD-related connectivity patterns could classify FEP as being LSD-like and vice versa. Subsequently, we investigated univariate RSFC between select networks, based on which network-interactions the classifiers suggested might overlap in LSD and FEP. Cross-application of externally validated LSD-placebo classifiers revealed partial overlap between LSD and FEP, particularly involving the dorsal attention network (DAN) and sensorimotor network (SMN). Application of the most discriminant FEP-HC network-interaction classifiers revealed that LSD displayed select similarities with FEP. Univariate network analysis also supports between-network DAN and SMN dysconnectivity being a point of convergence. Our findings indicate that neural correlates of FEP might have select overlaps with changes in brain functioning produced by LSD. These results suggest serotonergic dysfunction might play a role in the early stages of psychosis and necessitate future studies directly comparing FEP and LSD.
Authors
- Peter S. Hendricks (ORCID: https://orcid.org/0009-0004-8642-9584)
- Jessica A. Turner (ORCID: https://orcid.org/0000-0003-0076-8434)
- Undine Emmi Lang (ORCID: https://orcid.org/0000-0002-3585-6533)
- A. Becker (ORCID: https://orcid.org/0000-0001-5308-7945)
- Aaron Klaiber (ORCID: https://orcid.org/0009-0004-5199-7004)
- Patrick Vizeli (ORCID: https://orcid.org/0000-0002-5954-4446)
- Friederike Holze (ORCID: https://orcid.org/0000-0003-3143-1519)
- Rebecca Boehme (ORCID: https://orcid.org/0000-0003-2803-3069)
- Adrienne Carol Lahti (ORCID: https://orcid.org/0000-0002-5565-7662)
- Robin Lester Carhart-Harris (ORCID: https://orcid.org/0000-0002-6062-7150)
- Haley Maria Dourron (ORCID: https://orcid.org/0000-0002-1589-4081)
- Christopher R. N. Nicholas (ORCID: https://orcid.org/0000-0002-0599-4046)
- Felix Müller (ORCID: https://orcid.org/0000-0002-4582-6610)
- Matthias E. Liechti (ORCID: https://orcid.org/0000-0002-1765-9659)
- Manoj K. Doss (ORCID: https://orcid.org/0000-0003-2939-2522)
- Melissa K. Bradley
- Laura Ley (ORCID: https://orcid.org/0009-0003-9881-4693)
Institutions
- Linköping University (SE)
- University of Wisconsin–Madison (US)
- University of California, San Francisco (US)
- University of Basel (CH)
- University of Alabama at Birmingham (US)
- The Ohio State University (US)
- The University of Texas at Austin (US)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-18
- DOI
- https://doi.org/10.21203/rs.3.rs-11539750/v1
- Primary Topic
- Psychedelics and Drug Studies
- Type
- preprint